• SENSEX 78,890.97
    1,589.57 (+2.06%)
  • BANKNIFTY 55,913.60
    373.55 (+0.67%)
  • NSE
    1,850.00 1,878.00(%)
  • ITC
    277.30 252.80(%)
  • Tube Investments
    2,227.65 2,006.00(%)
  • Axis Bank
    1,274.70 1,418.30(%)
  • Reliance Industries
    1,303.90 1,152.30(%)
  • HDFC Life Insur.
    546.00 788.50(%)
  • Aurobindo Pharma
    1,748.85 1,739.95(%)
  • Lenskart Solut.
    767.40 725.00(%)
  • HDFC Bank
    762.80 1,017.90(%)
  • Titan Company
    4,858.90 5,187.45(%)
  • Petronet LNG
    320.00 326.40(%)
  • CG Power & Ind
    812.40 525.50(%)
  • Jio Platforms
    1,442.00 1,490.00(%)
  • Tonbo Imaging
    1,460.00 1,343.80(%)
  • Multi Comm. Exc.
    3,395.00 3,537.00(%)
  • Larsen & Toubro
    4,071.00 4,440.00(%)
  • Saregama India
    613.80 305.65(%)
  • Bajaj Finance
    1,054.00 1,177.60(%)
  • Cummins India
    4,036.95 3,883.30(%)
  • Bajaj Auto
    10,750.10 12,470.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Ind-Swift Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 7927.0
  • ISIN : INE915B01019
370.55 27 (7.80%)
  • As on 05 Nov 2026 (EOD)

  • Today’s Low

    345.50

  • Today’s High

    373.00

  • Open

    345.50

  • Perv Close

    343.75

  • 52W Low

    87.15

  • 52W High

    426.60

Key Indicators

  • P/E(TTM)

    36.08

  • Mar.Cap (₹Cr.)

    3,222.36

  • Div & Yield %

    0.00

  • Book Value(₹)

    167.85

  • Debt-Equity Ratio

    7.80

  • AGM Date

    04-Nov-2026

  • EPS

    10.30

  • P/E Ratio

    36.08

Financials Ratios

  • Debt-Equity Ratio

    0.61

  • Mar.Cap (₹Cr.)

    3,222.36

  • RONW (%)

    19.32

  • ROCE (%)

    20.71

Score Board

  • Equity (₹ in Cr.)

    86.96

  • BV (₹)

    167.90

  • Sales( ₹ in Cr.)

    635.89

  • NP (in Cr.)

    50.83

  • NP Var(%)

    1837.0

  • Div%

    0.0

  • CPS (₹)

    9.40

  • EPS (₹)

    5.80

  • Traded Value (₹ in Lakhs)

    3,231.93

  • 52 Week High

    426.60

  • 52 Week Low

    87.15

  • Price BSE

    372.0

  • Price NSE

    371.00

  • Market Capital( in Cr.)

    3,231.93

  • P/C Ratio

    39.70

  • P/E Ratio

    63.60

  • Price Vs.BV

    5.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 635.89 562.17 1,672.57 1,151.96 988.09 856.58
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 635.89 562.17 1,672.57 1,151.96 988.09 856.58
Other Income 46.96 291.95 479.29 33.28 42.50 23.13
Stock Adjustments 28.91 10.36 -66.92 12.34 39.47 2.48
Total Income 711.76 864.48 2,084.94 1,197.58 1,070.06 882.19
EXPENDITURE :            
Raw Materials 312.40 295.36 782.01 629.18 537.62 427.47
Power and Fuel Cost 16.42 13.72 73.61 76.07 58.40 37.31
Employee Cost 136.33 115.33 233.43 132.70 124.62 104.17
Other Manufacturing Expenses 42.85 37.50 57.15 38.53 36.51 28.76
Selling and Administration Expenses 102.24 97.07 122.77 63.98 62.17 78.98
Miscellaneous Expenses 19.33 13.97 37.86 28.40 16.22 1.87
Employee Benefit Expenses 136.33 115.33 233.43 132.70 124.62 104.17
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 629.56 572.94 1,306.83 968.85 835.54 678.56
Operating Profit 82.18 291.54 778.11 228.73 234.52 203.63
Interest 1.40 2.92 103.77 92.17 95.55 100.22
Gross Profit 80.78 288.62 674.34 136.56 138.97 103.41
Depreciation 30.57 24.48 80.41 57.36 130.97 87.29
Profit Before Tax 50.21 264.14 593.93 79.20 8.00 16.12
Current Tax 13.06 11.88 68.60 13.36 24.62 11.04
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -5.40 -3.83 -10.84 23.36 -10.92 9.48
Reported Net Profit 42.56 256.09 536.18 42.47 -5.71 -4.40
Extraordinary Items -8.27 259.01 389.96 -13.39 -3.13 0.00
Adjusted Net Profit 50.83 -2.92 146.22 55.86 -2.58 -4.40
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -142.89 -398.98 -935.16 -80.16 -74.45 -70.05
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -100.34 -142.89 -398.98 -37.69 -80.16 -74.45
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 4.90 37.25 79.77 7.10 -0.95 -0.74
Earnings Per Share(Adj)-Unit Curr 4.90 37.25 79.77 7.10 -0.95 -0.74
Book Value 157.74 158.56 118.75 82.26 72.91 71.55
Book Value(Adj)-Unit Curr 157.74 158.56 118.75 82.26 72.91 71.55

Shareholding Pattern

  • Promoter Group

    42.93%

  • Public Share Holding

    57.07%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 32,882,521 37.81 32,882,521 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 4,451,757 5.12 4,451,757 19
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 37,334,278 42.93 37,334,278 20
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 574 0.00 574 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 9,370,641 10.78 9,370,641 14
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 2,296 0.00 2,296 3
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 172,480 0.20 172,480 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 9,545,991 10.98 9,545,991 21
2] Non Institution
Bodies Corporate 5,430,678 6.24 5,420,878 247
Clearing Members 88,453 0.10 88,453 28
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,025,481 2.33 2,025,481 586
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 926,476 1.07 926,476 937
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 18,993,180 21.84 18,993,180 141
Individuals holding nominal share capital up to Rs. 1 lakh 11,793,811 13.56 11,673,463 40,650
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 706,270 0.81 706,270 4
Sub Total 40,081,289 46.09 39,951,141 42,626
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 86,961,558 100.00 86,831,410 42,667

Company Background

Ind-Swift Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Ind-Swift Laboratories Ltd
  • BSE Code : 7927.0
  • ISIN : INE915B01019

  • Incorporation Year

    1995

  • Registered Office

    SCO 850 Shivalik Enclave
    NAC Manimajra, Chandigarh,
    Chandigarh-160101

  • Telephone

    91-0172-5061850/2730920

  • FAX

    91-0172-2730504/2736294

  • Chairman

    N R Munjal

  • Managing Director

    N R Munjal

  • Company Secretary

    Pradeep Verma

  • Auditor

    Rattan Kaur & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Alankit Assignments Ltd
    205/208,
    Anarkali Market,Jhandewalan Extn
    Mumbai - New Delhi - 110055

Ind-Swift Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Ind-Swift Labs. 371.65 682.84 635.89 39.83 4.39
Abbott India 27,146.85 7,217.19 6,929.05 35.73 43.78
Astrazeneca Phar 6,365.10 2,304.07 2,275.58 93.81 27.86
Glaxosmi. Pharma 2,532.60 3,932.76 3,790.20 40.46 58.17
Evonile Pharma 1,736.60 393.10 354.33 43.85 15.94
Cipla 1,400.10 20,102.60 18,979.95 42.67 13.88
Bliss GVS Pharma 625.60 773.53 729.81 40.78 12.51
Amrutanjan Healt 511.45 520.13 502.55 27.39 24.16
Fermenta Biotec. 439.00 474.15 450.25 20.49 18.77
Guj. Themis Bio. 387.70 168.25 165.82 103.66 18.05
Ambalal Sarabhai 35.67 19.52 3.94 66.06 6.77